
In this video, the first in a 3-part series, panelists discuss recent advancements in RSV management.
A 3-part video series tackling updates and unmet needs in RSV in the wake of the clesrovimab approval in June 2025.

In this video, the first in a 3-part series, panelists discuss recent advancements in RSV management.

In this video, part 2 in a 3-part series, panelists discuss clesrovimab's recent approval and gaps in clinician education.

In this video, the last in a 3-part series, panelists discuss future directions in the field and the importance of multispecialty collaboration.